Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-06

Clinical Trial Update: Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the use of Surgicel in combination with endometrial ablation for managing perimenopausal heavy menstrual bleeding in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Surgicel (oxidized regenerated cellulose)

Snippet

Sponsor: Cairo University | Conditions: Endometrial Hyperplasia | Phase 2 | Status: UNKNOWN